112 results
Page 2 of 6
6-K
EX-99.1
c7qtf 0nqp7sw
30 Aug 23
Current report (foreign)
8:00am
6-K
EX-99.1
vpm r5thd7o
10 Aug 23
Report of Foreign Private Issuer
8:00am
6-K
EX-99.3
9ebvxcaxsm2e42v 51
10 Aug 23
Report of Foreign Private Issuer
8:00am
6-K
EX-99.2
atat1myub
10 Aug 23
Report of Foreign Private Issuer
8:00am
424B5
508m5yb40p6 4rl
12 Jul 23
Prospectus supplement for primary offering
12:00am
F-3
szz slb84
30 Jun 23
Shelf registration (foreign)
4:06pm
6-K
EX-99.1
qs6fgg7u
28 Jun 23
InflaRx Appoints Dr. Camilla Chong as Chief Medical Officer
8:30am
6-K
EX-99.1
emk 0j4g1
21 Jun 23
InflaRx Announces Commercial Launch of Gohibic (vilobelimab) in the U.S. for the Treatment of Critically Ill COVID-19 Patients
8:30am
6-K
EX-99.3
oy8sx w74vvtwbj85be
11 May 23
Current report (foreign)
8:00am
6-K
EX-99.2
3k07u91rzoje 454m2v8
11 May 23
Current report (foreign)
8:00am
6-K
EX-99.1
cdam4t0t3rs ofgzmc
11 May 23
Current report (foreign)
8:00am
424B5
yt1h2p0olv0e
13 Apr 23
Prospectus supplement for primary offering
8:48am
424B5
9i3 72aoydfxirp37f4a
11 Apr 23
Prospectus supplement for primary offering
4:11pm
6-K
EX-99.1
m8wn3km82ddmiasggn
21 Dec 22
Current report (foreign)
7:45am
6-K
EX-99.4
m4spf htp
9 Nov 22
Current report (foreign)
7:52am
6-K
EX-99.2
w2m1i5gxc3ivvs8h0m
9 Nov 22
Current report (foreign)
7:52am
6-K
EX-99.1
4up5xoh774de
9 Nov 22
Current report (foreign)
7:52am
6-K
EX-99.1
xeo1xq3
5 Aug 22
Current report (foreign)
6:07am
6-K
EX-99.2
7d1ywvxpy
5 Aug 22
Current report (foreign)
6:07am
6-K
EX-99.3
uhdzdlms
5 Aug 22
Current report (foreign)
6:07am